DOI:
10.1055/s-00030576
Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics
LinksClose Window
References
Delpech Y, Wu Y, Hess KR, Hsu L, Ayers M, Natowicz R. et al.
Ki67 expression in the primary tumor predicts for clinical benefit and time to progression on first-line endocrine therapy in estrogen receptor-positive metastatic breast cancer.
Breast Cancer Res Treat 2012;
135 (02) 619-627
DOI: 10.1007/s10549-012-2194-2.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.